Literature DB >> 7129551

Frequency and duration of acute filarial attacks in persons in Brugia malayi endemic community.

C K Rao, A Chandrasekharan, C Cherian.   

Abstract

Entities:  

Mesh:

Year:  1982        PMID: 7129551

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


× No keyword cloud information.
  6 in total

1.  Economic Costs and Benefits of Community-Based Lymphedema-Management Programs for Lymphatic Filariasis in India.

Authors:  Larry Sawers; Eileen Stillwaggon
Journal:  Am J Trop Med Hyg       Date:  2020-07       Impact factor: 2.345

2.  The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).

Authors:  Brian K Chu; Pamela J Hooper; Mark H Bradley; Deborah A McFarland; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

3.  Epidemiology of episodic adenolymphangitis: a longitudinal prospective surveillance among a rural community endemic for bancroftian filariasis in coastal Orissa, India.

Authors:  Bontha V Babu; Abhay N Nayak; Kalpataru Dhal
Journal:  BMC Public Health       Date:  2005-05-19       Impact factor: 3.295

4.  Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.

Authors:  David G Addiss; Molly A Brady
Journal:  Filaria J       Date:  2007-02-15

5.  Changes in Antibody Levels during and following an Episode of Acute Adenolymphangitis (ADL) among Lymphedema Patients in Léogâne, Haiti.

Authors:  Katherine E Mues; Patrick J Lammie; Mitchel Klein; David G Kleinbaum; David Addiss; LeAnne M Fox
Journal:  PLoS One       Date:  2015-10-22       Impact factor: 3.240

6.  Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.

Authors:  Eileen Stillwaggon; Larry Sawers; Jonathan Rout; David Addiss; LeAnne Fox
Journal:  Am J Trop Med Hyg       Date:  2016-08-29       Impact factor: 2.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.